APA način citiranja

Laliberté, F., Raut, M., Yang, X., Germain, G., Nahar, A., Desai, K. D., . . . Duh, M. S. (2020). Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA. Target Oncol.

Čikaški stil citiranja

Laliberté, François, Monika Raut, Xiaoqin Yang, Guillaume Germain, Akash Nahar, Kaushal D. Desai, Sean D. MacKnight, Shuvayu S. Sen, i Mei Sheng Duh. "Real-World Healthcare Resource Utilization in Patients With Classical Hodgkin Lymphoma Treated With Pembrolizumab and Nivolumab in the USA." Target Oncol 2020.

MLA način citiranja

Laliberté, François, et al. "Real-World Healthcare Resource Utilization in Patients With Classical Hodgkin Lymphoma Treated With Pembrolizumab and Nivolumab in the USA." Target Oncol 2020.